Moderna Inc. buy Barclays PLC
Start price
16.09.24
/
50%
€62.07
Target price
16.09.25
€112.33
Performance (%)
-65.73%
End price
17.09.25
€21.27
Summary
This prediction ended on 17.09.25 with a price of €21.27. Massive losses of -65.73% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 1.008% | 1.008% | 86.904% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Barclays_PLC for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $155.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten